 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
* C-alpha coords only
|
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
membrane
|
5 terms
|
 |
|
Biochemical function
|
protein binding
|
1 term
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
FEBS Lett
475:11-16
(2000)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural models for carcinoembryonic antigen and its complex with the single-chain Fv antibody molecule MFE23.
|
|
M.K.Boehm,
S.J.Perkins.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
MFE23 is a single chain Fv antibody that has a high affinity for
carcinoembryonic antigen (CEA). A full homology model for CEA based on V-type,
I-type and C2-type immunoglobulin folds, 28 oligosaccharides and the interdomain
angle of CD2 was validated using solution scattering data. The superimposition
of the intermolecular contacts observed in our recent crystal structure of MFE23
with the N-terminal domain of CEA permitted the MFE23-CEA complex to be
modelled. Good surface and electrostatic complementarity and
carbohydrate-unhindered access of MFE23 with the indentation between the first
two CEA domains was observed. The model is supported by biochemical data and
provides insight on the high affinity of MFE23 for CEA.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Fig. 1. Sequence alignment used for the modelling of CEA
based on homologous crystal structures. The 28 oligosaccharide
sites in CEA are denoted by bold underlining. Sequences are
labelled with their PDB code, and underlined regions indicate
the structures used to construct the CEA homology models. The
β-strands (E) identified by the DSSP program are labelled A to
G. a: The V-type domain of CEA is compared with the first V-type
domain in CD2, CD4 and CD8. b: The three I-type domains of CEA
are compared with that found in the first domain of VCAM-1. The
V-frame profile that resulted in the assignment to an I-type
domain is shown asterisked above the alignment. c: The three
C2-type domains of CEA are compared with that found in the
second domain of the cell-surface protein CD2.
|
 |
Figure 3.
Fig. 3. The predicted model of the MFE23 complex with CEA-1
and CEA-2. a: An electrostatic view of the CEA-1 and CEA-2
domains is shown, where a stripe of basic residues (Lys-15,
Arg-64, Lys-112, Lys-180, Arg-190 and Arg-191) at the interface
between the CEA-1 and CEA-2 domains is arrowed. b: The
α-carbons of these six basic residues are shown as blue spheres
in the ribbon view of the CEA homology model (V-type, yellow;
I-type, green) which is rotated by 180° about the vertical axis
relative to the electrostatic view of the CEA-1 and CEA-2
domains. These basic residues are complementary to a stripe of
acidic residues seen on the MFE23 electrostatic surface. These
acidic residues are located on the H1 and H2 loops of MFE23 and
at the N-terminus of the V[L] domain, and involve Asp-H31,
Asp-H52, Glu-H53, Asp-H56, Glu-H58 and Glu-L1. c: Comparison of
the oligosaccharide arrangement in CEA relative to the modelled
MFE23 binding site on CEA. A ribbon diagram of MFE23 (white) is
shown attached to the CEA-1 and CEA-2 domains (yellow and green
respectively), in which the CEA-1 and CEA-2 domains are shown in
the same orientation as the two domains in a. Seven
oligosaccharide chains at Asn-70 and Asn-81 in CEA-1 and at
Asn-118, Asn-148, Asn-163, Asn-170 and Asn-174 in CEA-2 are
shown in blue solid representations. These do not prevent MFE23
binding at the interface between the CEA-1 and CEA-2 domains.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the Federation of European Biochemical Societies:
FEBS Lett
(2000,
475,
11-16)
copyright 2000.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
D.Bannister,
B.Popovic,
S.Sridharan,
F.Giannotta,
P.Filée,
N.Yilmaz,
and
R.Minter
(2011).
Epitope mapping and key amino acid identification of anti-CD22 immunotoxin CAT-8015 using hybrid {beta}-lactamase display.
|
| |
Protein Eng Des Sel, 24,
351-360.
|
 |
|
|
|
|
 |
J.V.Jokerst,
J.Chou,
J.P.Camp,
J.Wong,
A.Lennart,
A.A.Pollard,
P.N.Floriano,
N.Christodoulides,
G.W.Simmons,
Y.Zhou,
M.F.Ali,
and
J.T.McDevitt
(2011).
Location of Biomarkers and Reagents within Agarose Beads of a Programmable Bio-nano-chip.
|
| |
Small, 7,
613-624.
|
 |
|
|
|
|
 |
C.Neylon
(2008).
Small angle neutron and X-ray scattering in structural biology: recent examples from the literature.
|
| |
Eur Biophys J, 37,
531-541.
|
 |
|
|
|
|
 |
H.Kogelberg,
B.Tolner,
G.J.Thomas,
D.Di Cara,
S.Minogue,
B.Ramesh,
S.Sodha,
D.Marsh,
M.W.Lowdell,
T.Meyer,
R.H.Begent,
I.Hart,
J.F.Marshall,
and
K.Chester
(2008).
Engineering a single-chain Fv antibody to alpha v beta 6 integrin using the specificity-determining loop of a foot-and-mouth disease virus.
|
| |
J Mol Biol, 382,
385-401.
|
 |
|
|
|
|
 |
A.Bonner,
C.Perrier,
B.Corthésy,
and
S.J.Perkins
(2007).
Solution structure of human secretory component and implications for biological function.
|
| |
J Biol Chem, 282,
16969-16980.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.M.Kneller,
T.Ehlen,
J.P.Matisic,
D.Miller,
D.Van Niekerk,
W.L.Lam,
M.Marra,
R.Richards-Kortum,
M.Follen,
C.Macaulay,
and
S.J.Jones
(2007).
Using LongSAGE to Detect Biomarkers of Cervical Cancer Potentially Amenable to Optical Contrast Agent Labelling.
|
| |
Biomark Insights, 2,
447-461.
|
 |
|
|
|
|
 |
R.D.Guest,
R.E.Hawkins,
N.Kirillova,
E.J.Cheadle,
J.Arnold,
A.O'Neill,
J.Irlam,
K.A.Chester,
J.T.Kemshead,
D.M.Shaw,
M.J.Embleton,
P.L.Stern,
and
D.E.Gilham
(2005).
The role of extracellular spacer regions in the optimal design of chimeric immune receptors: evaluation of four different scFvs and antigens.
|
| |
J Immunother (1997), 28,
203-211.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
|